Essity AB (publ) - ETTYF Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$26.35
+0 (0.00%)

This chart shows the closing price for ETTYF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Essity AB (publ) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ETTYF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ETTYF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Essity AB (publ) in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $26.35.

This chart shows the closing price for ETTYF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Sell

The current consensus among 1 contributing investment analysts is to sell stock in Essity AB (publ). This Sell consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
1/23/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
4/23/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
7/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
10/20/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
1/18/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
4/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
6/16/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
7/16/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/1/2023JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
6/20/2023HandelsbankenUpgradeMarket Perform ➝ Outperform
6/19/2023Jefferies Financial GroupUpgradeUnderperform ➝ Hold
1/30/2023HandelsbankenUpgradeUnderperform ➝ Market Perform
1/19/2023Berenberg BankBoost TargetHold ➝ HoldSEK 254 ➝ SEK 289
1/18/2023Jefferies Financial GroupDowngradeHold ➝ Underperform
12/1/2022JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral
11/22/2022Exane BNP ParibasUpgradeNeutral ➝ Outperform
10/31/2022JPMorgan Chase & Co.Boost TargetSEK 210 ➝ SEK 220
10/28/2022Credit Suisse GroupLower TargetOutperform ➝ OutperformSEK 308 ➝ SEK 286
9/14/2022BarclaysLower TargetSEK 236 ➝ SEK 232
7/22/2022Credit Suisse GroupBoost TargetOutperform ➝ OutperformSEK 300 ➝ SEK 308
7/19/2022Berenberg BankBoost TargetSEK 266 ➝ SEK 289
6/23/2022JPMorgan Chase & Co.Lower TargetUnderweight ➝ UnderweightSEK 260 ➝ SEK 255
6/23/2022BarclaysLower TargetEqual Weight ➝ Equal WeightSEK 268 ➝ SEK 236
6/23/2022UBS GroupLower TargetBuy ➝ BuySEK 305 ➝ SEK 300
5/11/2022Credit Suisse GroupUpgradeNeutral ➝ Outperform
5/3/2022UBS GroupBoost TargetBuy ➝ BuySEK 295 ➝ SEK 305
4/29/2022The Goldman Sachs GroupUpgradeSell ➝ Neutral
4/26/2022JPMorgan Chase & Co.Boost TargetSEK 250 ➝ SEK 260
4/26/2022HSBCUpgradeReduce ➝ Hold
4/25/2022BarclaysBoost TargetEqual Weight ➝ Equal WeightSEK 231 ➝ SEK 268
4/14/2022Kepler Capital MarketsDowngradeBuy ➝ Hold
4/4/2022UBS GroupLower TargetBuy ➝ BuySEK 352 ➝ SEK 295
3/30/2022BarclaysLower TargetEqual Weight ➝ Equal WeightSEK 277 ➝ SEK 231
1/28/2022UBS GroupLower TargetSEK 370 ➝ SEK 352
1/28/2022BarclaysLower TargetSEK 298 ➝ SEK 277
1/11/2022Exane BNP ParibasDowngradeOutperform ➝ Neutral
12/14/2021JPMorgan Chase & Co.Lower TargetUnderweight ➝ UnderweightSEK 310 ➝ SEK 305
12/1/2021Deutsche Bank AktiengesellschaftReiterated RatingHold
11/30/2021JPMorgan Chase & Co.Reiterated RatingUnderweight
11/22/2021UBS GroupUpgradeNeutral ➝ Buy
10/25/2021BarclaysReiterated RatingEqual Weight
10/25/2021JPMorgan Chase & Co.Reiterated RatingUnderweight
10/4/2021Societe GeneraleDowngradeBuy ➝ Hold
9/30/2021BarclaysReiterated RatingEqual Weight
9/9/2021HSBCInitiated CoverageReduce$235.00
9/2/2021JPMorgan Chase & Co.Reiterated RatingUnderweight
7/21/2021BarclaysReiterated RatingEqual Weight
7/20/2021Berenberg BankReiterated RatingHold
7/20/2021UBS GroupReiterated RatingNeutral
7/19/2021JPMorgan Chase & Co.Reiterated RatingUnderweight
5/27/2021Morgan StanleyReiterated RatingEqual Weight
4/28/2021Berenberg BankDowngradeBuy ➝ Hold
4/16/2021Jefferies Financial GroupDowngradeBuy ➝ Hold
4/1/2021Deutsche Bank AktiengesellschaftReiterated RatingHold
3/29/2021JPMorgan Chase & Co.Reiterated RatingUnderweight
2/8/2021Credit Suisse GroupDowngradeOutperform ➝ Neutral
1/29/2021BarclaysReiterated RatingEqual Weight
1/26/2021Berenberg BankUpgradeHold ➝ Buy
1/12/2021UBS GroupReiterated RatingNeutral
1/6/2021Societe GeneraleInitiated CoverageBuy
12/3/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
11/23/2020Morgan StanleyReiterated RatingEqual Weight
10/27/2020BarclaysReiterated RatingEqual Weight
10/27/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
10/27/2020Berenberg BankReiterated RatingHold
10/23/2020UBS GroupReiterated RatingNeutral
10/16/2020Berenberg BankInitiated CoverageHold
9/30/2020BarclaysReiterated RatingEqual Weight
9/23/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
7/16/2020BarclaysUpgradeHold
6/5/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Underweight
6/3/2020DNB MarketsDowngradeHold ➝ Sell
5/5/2020Morgan StanleyDowngradeOverweight ➝ Equal Weight
4/30/2020JPMorgan Chase & Co.Reiterated RatingOverweight
4/28/2020UBS GroupReiterated RatingNeutral
4/7/2020Morgan StanleyReiterated RatingOverweight
(Data available from 7/16/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/19/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/18/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/17/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/18/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/17/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/17/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/16/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/16/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Essity AB (publ) logo
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through Health & Medical, Consumer Goods, and Professional Hygiene segments. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, wet wipes, wash gloves, and digital solutions with sensor technology under the TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner, and Hydrofera brands to family caregivers, professional caregivers, and patients and consumers through pharmacies, medical device stores, hospitals, distributors, care institutions, and e-commerce. The Consumer Goods segment provides pads, panty liners, tampons, diapers, shampoos, lotions, baby oil, skin creams, intimate soaps, intimate wipes, leakproof apparel, washable absorbent underwear, menstrual cups, toilet papers, household towels, handkerchiefs, facial tissues, and napkins under the TENA, Knix, Modibodi, Libero, Lotus, Drypers, Libresse, Bodyform, Nana, Saba, Nosotras, Nuvenia TOM Organic, Tempo, Zewa, Cushelle, Plenty, Regio, Colhogar, and Familia brands through retail trade and e-commerce. The Professional Hygiene segment offers toilet papers, paper hand towels, napkins, hand soaps, hand lotions, hand sanitizers, dispensers, and cleaning and wiping products, as well as vision cleaning and data-driven cleaning solutions under the Tork brand to companies and office buildings, universities, healthcare facilities, industries, restaurants, hotels, stadiums, and other public venues through direct to the end-customer, e-commerce, or via distributors. Essity AB (publ) was founded in 1849 and is headquartered in Stockholm, Sweden.
Read More

Today's Range

Now: $26.35
Low: $26.35
High: $26.35

50 Day Range

MA: $25.91
Low: $23.62
High: $27.08

52 Week Range

Now: $26.35
Low: $20.90
High: $27.08

Volume

40 shs

Average Volume

2,099 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Essity AB (publ)?

The following equities research analysts have issued stock ratings on Essity AB (publ) in the last twelve months: JPMorgan Chase & Co..
View the latest analyst ratings for ETTYF.

What is the current price target for Essity AB (publ)?

0 Wall Street analysts have set twelve-month price targets for Essity AB (publ) in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Essity AB (publ) in the next year.
View the latest price targets for ETTYF.

What is the current consensus analyst rating for Essity AB (publ)?

Essity AB (publ) currently has 1 sell rating from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe ETTYF will underperform the market and that investors should sell shares of Essity AB (publ).
View the latest ratings for ETTYF.

What other companies compete with Essity AB (publ)?

How do I contact Essity AB (publ)'s investor relations team?

Essity AB (publ)'s physical mailing address is Klarabergsviadukten 63, Stockholm 101, 23. The company's listed phone number is (468) 788-5100. The official website for Essity AB (publ) is www.essity.com. Learn More about contacing Essity AB (publ) investor relations.